Study.EU
Your gateway to universities in Europe

Study at the University of Kent

Canterbury, United Kingdom

Cancer Biology and Therapeutics
  1. Study.eu
  2. United Kingdom
  3. University of Kent
  4. Cancer Biology and Therapeutics

Cancer Biology and Therapeutics

Master of Science at the University of Kent

Programme details
Degree: Master of Science (MSc)
Discipline: Human Medicine
Duration: 12 months
Study modes: full-time, part-time
Other students were also interested in this programme:
Master of Science
Reproductive Medicine: Science and Ethics
University of Kent (United Kingdom)

Learn more now


Description:

Gain an advanced education and training in the biological sciences, within the context of a disease that affects a large proportion of the global population.

The programme provides training in the modern practical, academic and research skills that are used in academia and industry. Through a combination of lectures, small-group seminars and practical classes, students apply this training towards the development of new therapies.

The programme culminates with a research project that investigates the molecular and cellular basis of cancer biology or the development of new therapies under the supervision of active cancer research scientists.

Kent and Medway Medical School

Kent is moving forward with the Kent and Medway Medical School (KMMS), due to take the first cohort of students in September 2020. 

KMMS will be a significant addition to the University, with exciting opportunities for education and research in the School of Biosciences.

Think Kent video series

In this lecture on cancer research, Professor Michelle Garrett discusses how collaboration between industry and academia is changing the face of cancer treatment.

About the School of Biosciences

The School of Biosciences is among the best-funded schools of its kind in the UK, with current support from the BBSRC, NERC, MRC, Wellcome Trust, EU, and industry. It has 40 academic staff, 56 research staff (facility managers, research fellows, postdoctoral researchers and technicians), approximately 100 postgraduate students and 20 key support staff. The school's vibrant atmosphere has expanded to become a flourishing environment to study for postgraduate degrees in a notably  friendly and supportive teaching and research environment.

Research in the School of Biosciences revolves around understanding systems and processes in the living cell. It has a strong molecular focus with leading-edge activities that are synergistic with one another and complementary to the teaching provision. Our expertise in disciplines such as biochemistry, microbiology and biomedical science allows us to exploit technology and develop groundbreaking ideas in the fields of genetics, molecular biology, protein science and biophysics. Fields of enquiry encompass a range of molecular processes from cell division, transcription and translation through to molecular motors, molecular diagnostics and the production of biotherapeutics and bioenergy.

In addition to research degrees, our key research strengths underpin a range of unique and career-focused taught Master’s programmes that address key issues and challenges within the biosciences and pharmaceutical industries and prepare graduates for future employment.


Copyright © 2021 Study.EU



Imprint · About Study.eu · Privacy Policy · Jobs
Press

Advertise on Study.eu
Study in Europe:
Austria
Belgium
Czech Republic
Denmark
Estonia
Faroe Islands
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Malta
Netherlands
Norway
Poland
Portugal
Romania
Russia
Spain
Sweden
Switzerland
United Kingdom
Recent articles:

US students: How to use FAFSA for a degree in Europe

Impact of COVID-19 on studying abroad in Europe: Overview

Guide: the UK Post-Study Work Visa for graduates

Study Ecology: All you need to know

Study Human Resource Management: All you need to know

Study.EU has been mentioned in numerous news publications worldwide, such as:
L'Étudiant (France)
Frankfurter Allgemeine (Germany)
The Standard (Hong Kong)
The Independent (UK)
Al-Masry Al-Youm (Egypt)
Le Monde (France)
The Local (Europe)
Forbes (USA)
Cookies & analytics help us deliver our services. Privacy policy